At Lilly, we take smart risks on bold science to discover treatments and cures, all for one reason – patients. As a community of scientists, we recognize our responsibility as partners to help advance innovative medicines within our organization and beyond it. We understand that every partnership is unique – with distinctive aspects such as the stage, modality, therapeutic area, and culture. We have the necessary skills, capabilities, and know-how to bring a complete range of models to life and meet your specific needs. We approach every partnership with confidence, thoughtfulness, and enthusiasm. Together, we can make a difference in the lives of patients around the world.
Lilly is mainly looking for opportunities to work with external partners in the following scientific areas: Diabetes, Obesity and Cardiometabolic Diseases, Immunology, Neuroscience, Oncology, Adjacent Therapeutic Areas Indications, Emerging Technology and Platforms (including Genetic Medicines and Molecule Innovation), Health Tech, Diagnostics, Drug Delivery, R&D Tools, and Manufacturing, and Biotechnology Discovery Research.
Log in to BIO Partnering™ to send us a meeting request.
Adrienne Brown
Group VP - Head of Corporate Business Development
“At Lilly, our mission is clear: to put patients at the heart of everything we do. Through our Corporate Business Development team, we build partnerships that push boundaries, turning bold science into transformative healthcare solutions. Together, we create opportunities from challenges and drive life-saving innovations that improve lives worldwide—one partnership at a time.”

Nisha Nanda
Group VP - Business Development, Head of Lilly Catalyze360
“Catalyze360 doesn’t just partner with biotech companies—we walk alongside them, supporting them every step of their journey. We offer a comprehensive suite of resources, including access to funding through Lilly Ventures, cutting-edge lab space, technology, and mentorship at Lilly Gateway Labs, and the unmatched expertise of our R&D team via ExploR&D. Our collaborations are built on a shared vision and unified mission to accelerate science into meaningful solutions for patients around the world. Together, we pave the way for tomorrow’s breakthroughs.”

CORPORATE BUSINESS DEVELOPMENT

Jake Shuman
VP - Global Head of Transactions and M&A

Wanda Rutledge-Gordon
VP - Global Head of Alliance and Innovation Management
CATALYZE360

Brad Robling
VP - Global Head of Lilly Ventures

Jim MacKrell
VP - Lilly Ventures

Julie Gilmore
VP - Global Head of Lilly Gateway Labs

Tom Hopkins
VP - Global Head of Lilly ExploR&D
SEARCH & EVALUATION

Benjamin Yaden
VP - Global Head Diabetes, Obesity and Cardiometabolic Diseases Search & Evaluation

David Shrom
VP - Global Head Immunology Search & Evaluation

Jenny Laird
VP - Global Head Neuroscience (Neurology and Pain) Search & Evaluation

Hallee Foster
VP - Global Head Neuroscience (Psychiatry) Search & Evaluation
SEARCH & EVALUATION

Tyler Robinson
VP - Global Head Oncology Search & Evaluation

Christalyn Rhodes
VP - Global Head Genetic Medicine Search & Evaluation

Andrew Korytko
VP - Molecule Innovation (Biologics) Search & Evaluation

Jim Koers
Executive Director - CMC for Business Development